Synergistic Effects of Chinese Herbal Medicine: A Comprehensive Review of Methodology and Current Research.

Zhou X, Seto SW, Chang D, Kiat H, Razmovski-Naumovski V, Chan K, Bensoussan A. · 2016

Read Synergistic Effects of Chinese Herbal Medicine: A Comprehensive Review of Methodology and Current Research. by Zhou X, Seto SW, Chang D, Kiat H, Razmovski-Naumovski V, Chan K, Bensoussan A. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4940614.txt.

Introduction

Xian Zhou and six co-authors review synergy in Chinese herbal medicine and the weak state of its proof. Their review appeared in Frontiers in Pharmacology in 2016. Herbal formulas mix two or more medicinal herbs and have treated disease in Asia for thousands of years. Many assume the mix works better than its parts. The authors argue that this claim is often asserted with loose methods and a muddy sense of what synergy means.

The review first separates true synergy from simple additive effects. It then grades the main test methods, from isobolographic analysis and the combination index to systems biology models. Each has strengths and blind spots with complex herb mixes. Some data back synergy in herb pairs and herb drug pairs, the authors find, but the overall level of evidence stays low. They call for stricter designs before clinical claims are made.

Catalog record

CREATORZhou X, Seto SW, Chang D, Kiat H, Razmovski-Naumovski V, Chan K, Bensoussan A.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4940614

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Synergistic Effects of Chinese Herbal Medicine: A Comprehensive Review of Methodology and Current Research By Xian Zhou, Sai Wang Seto, Dennis Chang, Hosen Kiat, Valentina Razmovski-Naumovski, Kelvin Chan, Alan Bensoussan Published in: Frontiers in Pharmacology DOI: 10.3389/fphar.2016.00201 ABSTRACT Traditional Chinese medicine (TCM) is an important part of primary health care in Asian countries that has utilized complex herbal formulations (consisting 2 or more medicinal herbs) for treating diseases over thousands of years. There seems to be a general assumption that the synergistic therapeutic effects of Chinese herbal medicine (CHM) derive from the complex interactions between the multiple bioactive components within the herbs and/or herbal formulations. However, evidence to support these synergistic effects remains weak and controversial due to several reasons, including the very complex nature of CHM, misconceptions about synergy and methodological challenges to study design. In this review, we clarify the definition of synergy, identify common errors in synergy research and describe current methodological approaches to test for synergistic interaction. We discuss the strengths and weaknesses of these models in the context of CHM and summarize the current status of synergy research in CHM. Despite the availability of some scientific data to support the synergistic effects of multi-herbal and/or herb-drug combinations, the level of evidence remains low, and the clinical relevancy of most of these findings is undetermined. There remain significant challenges in the development of suitable methods for synergistic studies of complex herbal combinations. INTRODUCTION The “one drug, one target, one disease” approach has for some time remained the conventional pharmaceutical approach to the development of medicines and treatment strategies. However, over the last decade, this mono-substance therapy model has gradually shifted toward the adoption of combination therapies, in which multiple active components are employed. This paradigm shift has been partly driven by its limited effectiveness in chronic diseases, treatment resistance, and side effects of synthetic mono-drugs. Recent evidence has demonstrated that combination therapy could provide greater therapeutic benefits to diseases such as AIDS, cancer, atherosclerosis and diabetes, all of which possess complex etiology and pathophysiology and therefore are difficult to treat using single drug target approach (Devita et al., 1975; Chesney et al., 2000; Jukema and van der Hoorn, 2004; Weber and Noels, 2011). Moreover, advances in analytical chemistry and molecular biology methods have broadened our understanding of therapeutic targets of diseases and potential multi-target treatment approaches. Significant progress has been made in the study of synergistic effects of drugs. For instance, a recent study has demonstrated the synergistic effect of the combination of metformin and aspirin in treating pancreatic cancer (Yue et al., 2014). In parallel, research into synergistic interactions of multi-component herbal preparations and their interactions with pharmaceutical drugs has also attracted great interest in recent years. Traditional Chinese medicine (TCM) has been used over thousands of years for the management of disease, maintenance of health, and prolongation of life expectancy in China and other Asian countries such as Japan and Korea. Chinese herbal medicine (CHM) is a key modality of TCM, in which up to 20 herbs are used in combination in a complex herbal formulation. Substantial progress has been made over the last decades in the study of efficacy and mode of actions of some commonly used herbs and formulations (Lam et al., 2006; Kong et al., 2009). However, evidence to support synergistic effects of multiple herbs and their active components remains controversial. For example, some studies have suggested that meaningful synergistic and therapeutic effects of herbal formulations were unlikely due to the low/extremely low levels of active components existed in the herbs (Williamson, 2001; Danz et al., 2002). This has led to skepticism that herbal therapies are merely placebo effects (Tausk, 1998). In contrast, numerous studies have demonstrated that herbal extracts as a whole and/or multiple herbs in complex formulations offer better efficacies than equivalent doses of individual active ingredients and/or herbs when used alone, highlighting the significance of synergistic action in herbal therapies (Leonard et al., 2002; Scholey and Kennedy, 2002; Zhang et al., 2014). In this article, we aim to present a comprehensive review of the current status of research on the synergistic effects of CHM and how they are effectively measured. DEFINITION OF SYNERGY Generally, synergy is defined as the interaction of two or more agents to produce a combined effect greater than the sum of their individual effects (van Vuuren and Viljoen, 2011). In medicinal research field, however, the understanding of synergy is complicated. Spinella (2002) has classified the concept of synergy broadly into two main categories based on the mode of actions—pharmacodynamic and pharmacokinetic synergy (Spinella, 2002). The first type of synergy describes two or more agents that work on the same receptors or biological targets that result in enhanced therapeutic outcomes through their positive interactions. The second type of synergy results from interactions between two or more agents during their pharmacokinetic processes (absorption, distribution, metabolism and elimination) leading to changes of the agents quantitatively in the body and hence their therapeutic effects (Spinella, 2002). The concept of synergy is an intrinsic part of TCM philosophy and is often described in a more holistic way. The complex synergistic interactions among the herbs in complex CHM formulations (Fufang) are believed to be able to enhance the bioavailability of active components, promote therapeutic effects, and/or reduce toxicity (Jia et al., 2004). The design of herbal formulations follows the principle of compatibility, called “Peiwu,” which requires the considerations of different interrelationships of herbal ingredients including synergism (Xiang Xu), assisting (Xiang Shi), detoxication (Xiang Sha and Xiang Wei), antagonism (Xiang Wu), and rejection (Xiang Fan) (Jia et al., 2004). Based on this principle, different herbs are combined following “Jun-Chen-Zuo-Shi” (also known as “Emperor–Minister-Assistant-Courier”) rule to achieve desirable effects and/or to minimize side-effects. “Jun” is the main herb in a herbal formula with a relatively higher ratio directly targeting the disease; “Chen” is an adjuvant herb to promote therapeutic effect of the key herb or to target the accompanying symptoms; “Zuo” is usually used for reducing the side-effects of the herbal formula; “Shi” is the herb that guides the active ingredients to reach the target organs or to harmonize their actions. It is important not to confuse synergistic effect with additive effect. Synergy occurs when two or more drugs/compounds are combined to produce a total effect that is greater than the sum of the individual agents (Chou, 2010; Breitinger, 2012), while an additive effect is an add up of individual effects where each individual agent is not affecting the other (no interactions). The concept that the additive effect of two drugs is their “arithmetic sum” is a misconception. The additive effect is not simply the sum of the effects of A plus B. For instance, if agents A and B exert an inhibitory effect as 60 and 70% at certain dosage level, respectively, it is incorrect to state their additive effect is 130% at this dosage. The additive effect needs to be determined using a more complex mathematical algorithm equation. Comparing combination activity to individual activity at the same dosage or effect level is a common error in synergy studies. A large amount of papers were found to report synergistic effect when the ED50 value of a combination was significantly lower than

Read the complete text